TLX filings
Corporate insider profile
Christian Behrenbruch Filing Activity
Latest reported as MD & Group CEO of Telix Pharmaceuticals Ltd (TLX).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $996,736
- Latest transaction
- Apr 29, 2026
Affiliated corporations
Reported company relationships
Transaction history
